A prospective, multicentre, observational study on the use of CMV hyperimmunoglobulins after heart and lung transplantation
Latest Information Update: 31 Jan 2023
At a glance
- Drugs Cytomegalovirus immune globulin (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
Most Recent Events
- 31 Jan 2023 New trial record
- 24 Jan 2023 According to a Biotest AG media release, first patient treated with Cytotect CP Biotest after heart and lung transplantation, has been enrolled.